Sugary drinks may increase risk of metastasis in advanced colorectal cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 19-Sep-2025 13:11 ET (19-Sep-2025 17:11 GMT/UTC)
The principle of "food and medicine homology" (FMH), deeply embedded in traditional Chinese medicine, posits that certain natural substances can function as both food and medicine. A recent opinion piece posits that substances with FMH properties, recognized for their nutritional benefits and minimal toxicity, may present innovative opportunities in supplementary cancer treatment and prevention. The authors underscore the solid theoretical underpinnings and international acknowledgement of this approach, emphasizing how cutting-edge technologies can substantiate these age-old practices and facilitate their incorporation into modern, comprehensive cancer management programs.
A collaborative research team from Peking University has developed a novel method to enhance the tumor-targeting efficiency of γδ T cells through chemical engineering. By conjugating or gluing the cancer cell-targeting antibodies to γδ T cells via fast metabolic glycan labeling and click chemistry, the team achieved improved anti-tumor efficacy both in vitro and in vivo. This innovative approach holds significant promise for advancing adoptive cell therapy in cancer treatment.
Neoadjuvant therapies, or treatments given before surgery, are changing how doctors treat locally advanced colon cancer. In a recent review, researchers from the United States examined how pre-surgical chemotherapy and immunotherapy can shrink tumors, reduce recurrence, and improve surgical outcomes. They discussed clinical trials like FOxTROT and NICHE and highlighted the importance of using mismatch repair (MMR) status to guide treatment decisions and improve patient outcomes through personalized care strategies.
Cervical cancer is the fourth most common cancer among women globally, according to the World Health Organization. It accounted for 660,000 new cases and 350,000 deaths in 2022.
Screening, along with early detection and treatment, can greatly improve a patient’s chances of survival. But in low- to middle-income countries, many women are not being screened, and they’re disproportionately dying from the disease.
In new research from Texas McCombs, Anima Nivsarkar, a doctoral student in marketing, uncovers a powerful tool to boost screening: trust. When messages are delivered by trusted and credible sources such as doctors and peers, they increase the likelihood that women will seek potentially life-saving exams.
Twenty-seven species of bacteria and fungi among the hundreds that live in people’s mouths have been collectively tied to a 3.5 times greater risk of developing pancreatic cancer, a study led by NYU Langone Health and its Perlmutter Cancer Center shows.